Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | Day Return | YTD Return |
|---|---|---|---|
| All Industries | 100% | -0.13% | 0.23% |
| Drug Manufacturers - General | 34.13% | -0.18% | 5.95% |
| Healthcare Plans | 13.74% | 2.76% | -4.05% |
| Medical Devices | 12.92% | -0.91% | 1.91% |
| Diagnostics & Research | 11.15% | -0.94% | -2.18% |
| Biotechnology | 11.04% | -1.08% | -9.82% |
| Medical Instruments & Supplies | 6.68% | -0.03% | 1.13% |
| Medical Care Facilities | 2.81% | -2.78% | 4.04% |
| Drug Manufacturers - Specialty & Generic | 2.67% | -0.01% | -10.73% |
| Medical Distribution | 2.44% | -0.79% | 9.28% |
| Health Information Services | 2.17% | 0.69% | 7.04% |
| Pharmaceutical Retailers | 0.24% | -0.26% | -32.34% |
Note: Percentage % data on heatmap indicates Day Return
All Industries
-
Largest Companies in This Sector
Name | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 745.95 | 826.53 | 11.40% | Buy | ||||
| 493.18 | 569.69 | 7.31% | Buy | ||||
| 145.74 | 175.41 | 5.64% | Buy | ||||
| 125.23 | 137.02 | 5.10% | Buy | ||||
| 164.66 | 184.49 | 4.69% | Buy | ||||
| 541.52 | 606.63 | 3.32% | Buy | ||||
| 105.27 | 126.74 | 2.94% | Buy | ||||
| 236.36 | 265.76 | 2.81% | Buy | ||||
| 25.39 | 31.10 | 2.31% | Buy | ||||
| 262.75 | 307.50 | 2.26% | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 138.43 | 41.319B | 0.09% | ||
| 252.83 | 21.195B | 0.10% | ||
| 124.64 | 7.632B | 0.45% | ||
| 83.48 | 7.551B | 0.35% | ||
| 54.53 | 5.76B | 0.40% |
Mutual Fund Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 201.59 | 47.432B | 0.29% | ||
| 85.00 | 47.432B | 0.29% | ||
| 126.58 | 21.195B | 0.10% | ||
| 89.15 | 15.399B | 0.80% | ||
| 89.40 | 14.712B | 0.80% |
Healthcare Research
Discover the Latest Analyst and Technical Research for This Sector
Analyst Report: Johnson & Johnson
Johnson & Johnson is a diversified global healthcare company that develops, manufactures and markets products in two business segments: Innovative Medicine (formerly Pharmaceuticals) and MedTech.
RatingBullishPrice TargetMarket Update: DFS, JNJ, LVS, TRV
U.S. stocks were higher on Thursday morning. Initial jobless claims were 212,000 for the latest week, unchanged from the previous-week's revised level. Ongoing unemployment was 1,812,000, virtually unchanged from the previous week. The Dow was up 0.5%, the S&P 500 rose 0.4% and the Nasdaq gained 0.3%. Crude oil is trading above $82 per barrel and gold rose $9 to $2397 per ounce.
Analyst Report: Elevance Health, Inc.
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
RatingNeutralPrice TargetAnalyst Report: AbbVie Inc
AbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013. The company is based in suburban Chicago. The shares are a component of the S&P 500.
RatingNeutralPrice Target
